| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +0.00% | +3.74% | +1.60% | +2.14% | +2.14% | — |
| 14d | 1 | +0.00% | +0.81% | +1.24% | -0.44% | -0.44% | — |
| 30d | 1 | +0.00% | +2.49% | +1.79% | +0.70% | +0.70% | — |
| 60d | 1 | +100.00% | -1.54% | -0.42% | -1.12% | -1.12% | — |
| 90d | 1 | +0.00% | +8.72% | -4.00% | +12.72% | +12.72% | — |
| 180d | 1 | +0.00% | +12.53% | +9.31% | +3.22% | +3.22% | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 101,500 | — | — | 101,500 | Jan 2, 2026 | Jan 2, 2026 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | SALE Chief Medical Officer | 2,714 | $13.73 | $37.3K | 23,286 | Jan 2, 2026 | Jan 2, 2026 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 29,000 | — | — | 52,286 | Jan 2, 2026 | Jan 2, 2026 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 26,000 | — | — | 26,000 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |
| JANX JANUX THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 91,000 | — | — | 91,000 | Jan 2, 2025 | Jan 3, 2025 ↗ | View → |